Considering the study is funded for other expectations and outcomes for research purposes...the analyzer and SCAMydx should never be mentioned, not because of a CTO that has zero impact or relevance for the UF study and parties, but because the study was developed to identify what individuals are doing on their own for self medicating.
The analyzer has zero impact on the success of the study. And it was only requested to see if there is any usefulness of the analyzer for helping to gather individual self medicating practices.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.